Stephanie Berg (@bergsa83) 's Twitter Profile
Stephanie Berg

@bergsa83

Instructor of Medicine, Harvard Medical School. Medical oncologist at Lank Center for GU Oncology, Dana-Farber Cancer Institute. Alliance Executive Officer

ID: 2710047134

calendar_today05-08-2014 18:49:03

855 Tweet

817 Takipçi

219 Takip Edilen

Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

🎉 We're celebrating 25 years of building "Bridges to Cure" in #kidneycancer at #IKCSNA24! 📈ABSTRACTS accepted through Aug 22 📝EARLY REGISTRATION RATES available now. Join us this November! Submit abstracts and register: kidneycancer.org/ikcs/2024-ikcs…

🎉 We're celebrating 25 years of building "Bridges to Cure" in #kidneycancer at #IKCSNA24! 

📈ABSTRACTS accepted through Aug 22

📝EARLY REGISTRATION RATES available now. 

Join us this November! Submit abstracts and register: kidneycancer.org/ikcs/2024-ikcs…
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

Submit your abstracts for #IKCSNA24 today! bit.ly/45CgNiV We are accepting abstracts on a variety of #kidneycancer topics through August 22. #rcc #renalcellcarcinoma #cancerresearch

Submit your abstracts for #IKCSNA24 today! bit.ly/45CgNiV 

We are accepting abstracts on a variety of #kidneycancer topics through August 22. 

#rcc #renalcellcarcinoma #cancerresearch
Dr. Buzz Aldrin (@therealbuzz) 's Twitter Profile Photo

July 20th, 1969 is a date that stands high in my life – it was the day that we, together as one people, achieved the greatest scientific and technological feat in human history. The specific role that Neil, Mike and I performed in the event was but one part of an immeasurably

July 20th, 1969 is a date that stands high in my life – it was the day that we, together as one people, achieved the greatest scientific and technological feat in human history. The specific role that Neil, Mike and I performed in the event was but one part of an immeasurably
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

ONE MONTH to submit abstracts for #IKCSNA24! We are accepting #kidneycancer research in a variety of topic areas; we welcome encore research. Top abstracts are selected for oral presentations and Merit Awards! See you in Louisville, KY this Nov 7-9! kidneycancer.org/ikcs/2024-ikcs…

ONE MONTH to submit abstracts for #IKCSNA24! 

We are accepting #kidneycancer research in a variety of topic areas; we welcome encore research. Top abstracts are selected for oral presentations and Merit Awards! 

See you in Louisville, KY this Nov 7-9! kidneycancer.org/ikcs/2024-ikcs…
Dana-Farber News (@danafarbernews) 's Twitter Profile Photo

“I try to meet them where they are, listen to their stories, align our goals of treatment with their goals of life, and help them thrive,” says Vinayak Venkataraman, MD, one of the leaders of the Adolescent and Young Sarcoma Program (AYA) Dana-Farber. #SarcomaAwarenessMonth

Dana-Farber Lank Center for Genitourinary Oncology (@danafarber_gu) 's Twitter Profile Photo

A jam-packed GU Research Digest for the 2 weeks (sorry for the delay!) of July 13 - 26: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

A jam-packed GU Research Digest for the 2 weeks (sorry for the delay!) of July 13 - 26: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

Register today and submit your abstracts for #IKCSNA24 this fall. Abstracts are due by August 22: bit.ly/45CgNiV #rcc #renalcellcarcinoma #cancerresearch

Register today and submit your abstracts for #IKCSNA24 this fall. Abstracts are due by August 22: bit.ly/45CgNiV 

#rcc #renalcellcarcinoma #cancerresearch
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

Abstract submissions for #IKCSNA24 are due by August 22. Submit today and join the KCA at our 2024 IKCS: North America in Louisville, KY. Submit here: bit.ly/45CgNiV #rcc #renalcellcarcinoma #cancerresearch

Abstract submissions for #IKCSNA24 are due by August 22. Submit today and join the KCA at our 2024 IKCS: North America in Louisville, KY. Submit here: bit.ly/45CgNiV 

#rcc #renalcellcarcinoma #cancerresearch
Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

That's a wrap for BCAN's 2024 Think Tank, #BCANTT24. Thank you everyone for 2.5 amazing days of learning, collaboration, catching up with old friends and making new ones. We can't wait to see you next year in Washington, DC for #BCANTT25!

That's a wrap for BCAN's 2024 Think Tank, #BCANTT24.  Thank you everyone for 2.5 amazing days of learning, collaboration, catching up with old friends and making new ones.  We can't wait to see you next year in Washington, DC for #BCANTT25!
Dana-Farber Lank Center for Genitourinary Oncology (@danafarber_gu) 's Twitter Profile Photo

GU Research Digest for the week of August 3 - 9: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

GU Research Digest for the week of August 3 - 9: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

Abstract submissions for #IKCSNA24 are due soon! Submit your research and join the KCA at our 2024 IKCS: North America in Louisville, KY. Submit here: bit.ly/45CgNiV #rcc #renalcellcarcinoma #cancerresearch

Abstract submissions for #IKCSNA24 are due soon! Submit your research and join the KCA at our 2024 IKCS: North America in Louisville, KY. Submit here: bit.ly/45CgNiV 

#rcc #renalcellcarcinoma #cancerresearch
NEJM (@nejm) 's Twitter Profile Photo

In participants with advanced renal-cell carcinoma, belzutifan, a HIF-2α inhibitor, was superior to everolimus, an mTOR inhibitor, with respect to progression-free survival and tumor response. Read the full LITESPARK-005 trial results: nej.md/4cvmO2R

In participants with advanced renal-cell carcinoma, belzutifan, a HIF-2α inhibitor, was superior to everolimus, an mTOR inhibitor, with respect to progression-free survival and tumor response. Read the full LITESPARK-005 trial results: nej.md/4cvmO2R
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

We're bringing #IKCSNA24 to Louisville! 📊 Abstract submissions open through Sept 3 (Extended!) 🐣 Early bird registration through Oct 10 See you for the 2024 IKCS: North America in Louisville, KY from Nov 7-9! bit.ly/45CgNiV

Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

😎 We're heading into the long weekend, the perfect time to polish and submit your #IKCSNA24 abstracts! Submit your #kidneycancer research by 9/3: bit.ly/45CgNiV #rcc #renalcellcarcinoma #cancerresearch

😎 We're heading into the long weekend, the perfect time to polish and submit your #IKCSNA24 abstracts! Submit your #kidneycancer research by 9/3: bit.ly/45CgNiV 

#rcc #renalcellcarcinoma #cancerresearch
Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

⌛ FINAL DAY!! Today is the last day to submit your #IKCSNA24 abstract! We want to see your best #kidneycancer research. Submit here: bit.ly/45CgNiV #rcc #renalcellcarcinoma #cancerresearch